Ellinas Finance Public Company LTD

Business and Financial Review • Jan 19, 2022

January 19, 2022

Cyprus Stock Exchange Nicosia

SUPPLEMENTARY ANNOUNCEMENT

Subject: Sale of the Investment in NIPD Genetics Public Company Ltd from Ellinas Finance Public Company Limited

Ellinas Finance Public Company Limited ("ELF") under the applicable law and for the sake of transparency and in order to fully inform Company's shareholders and the investing public, announces that it has sold all the shares it had in NIPD Genetics Public Company Ltd ("NIPD") to Medicover Investment B.V. ("Medicover").

NIPD was established in October 2010 with the primary goal of designing, developing and manufacturing a non-invasive prenatal diagnosis of down Syndrome (Trisomy 21) and other genetic diseases. Today NIPD provides an expansive portfolio of prenatal, reproductive, postnatal and oncology tests, as well as clinical laboratory tests.

Taking into account the increase in sales of recent years and the future prospects of NIPD, interest was generated for the acquisition of the shares of NIPD held by ELF and other shareholders of NIPD, and ELF reached a profitable agreement to sell the shares at a significantly higher price compares to their purchase cost.

ELF owned before the sale, 452 shares (1,2% of total issued shares of NIPD) with an investment cost of €303.000. The sale price reached to €1.600 per share resulting in total income from sale €723.200. The sale of the shares will result in a net profit for the Company of €420.200. The decision to sell the shares of NIPD was taken after examination of all the data by the BOD of ELF and based on the above information it was not deemed necessary to seek advice of an expert. The transaction was completed on January 11, 2022.

Medicover Investment B.V. increase of ownership in NIPD Genetics Ltd from 18,9% to 87,2% is of strategic importance for NIPD Genetics Ltd as it will help bolster research and development and at the same time help promote the existing solutions of NIPD Genetics Ltd in other markets through their existing network.

The transaction was at arm's length and is not related to or affects directly or indirectly the interest of the ELF Secretary, or the interests of any 'designated person' in the sense ascribed by the Cyprus Stock Exchange and Securities Act.

Constantinos Servos, Compliance officer

CC. Cyprus Securities and Exchange Commission